4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001725663-26-000005
Chief Financial Officer sold 2,500 shares at $12.95 ($32,375)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
WENTWORTH KORY JAMES · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-01 | Sale : show line 1 in the form 10b5-1 | −2,500 | $12.95 | $32,375 | 119,010 | D |
| Open-market sales · 2,500 sh · avg $12.95 · $32,375 | ||||||
Loading xslF345X06/wk-form4_1775162353.xml…